Evidence map›Paper›PMID 21935717›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2012

Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials.

David Hui, Joseph Arthur, Shalini Dalal, Eduardo Bruera

Abstract readReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David HuiDepartment of Palliative Care & Rehabilitation Medicine Unit 1414, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. dhui@mdanderson.org
Joseph Arthur
Shalini Dalal
Eduardo Bruera

Funding

Parenteral Hydration in Advanced Cancer Patients: A Randomized Controlled TrialR01CA122292 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BRUERA, EDUARDO · 2006 to 2009
$2.2M
Methylphenidate for Fatigue in Advanced Cancer PatientsR01NR010162 · NINR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BRUERA, EDUARDO · 2006 to 2009
$1.3M
Morphine versus Methadone as First Line Strong Opioid for Cancer PainR01CA124481 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BRUERA, EDUARDO · 2007 to 2009
$1.2M
NCI NIH HHS R01 CA122292NCI NIH HHS R01CA122292-01NCI NIH HHS R01 CA124481NCI NIH HHS R01CA124481-01NINR NIH HHS R01 NR010162NINR NIH HHS R01NR010162-01A1
6 · The paper itself

Abstract

purposeThe quality of the supportive and palliative oncology literature is unclear. We examined five indicators of study quality in the supportive and palliative oncology literature.

methodsWe systematically searched MEDLINE, PsychInfo, EMBASE, ISI Web of Science, and CINAHL for original studies related to "palliative care" and "cancer" during the first 6 months of 2004 and 2009. For each study, we extracted the study size, the sample size calculation, and other study characteristics. We also determined the Consolidated Standards of Reporting Trials (CONSORT) overall quality score, the key methodologic index, and the Jadad score for randomized controlled trials (RCTs).

resultsA total of 840 studies were included for sample size analysis, and 44 RCTs were identified for quality of reporting analysis. The median sample size was 70 for RCTs, 112 for cohort studies, and 200 for cross-sectional studies. Sample size calculations were most frequently reported in RCTs; however, 29/44 (66%) RCTs had no reporting, 5/44 (11%) had partial reporting, and 10/44 (23%) had full reporting. The median CONSORT overall quality score was 9 (interquartile range 7-11), key methodologic index was 0.50 (interquartile range 0-1.75), and Jadad score was 2 (interquartile range 1-3), suggesting low quality of reporting. We found no differences in the quality scores between 2004 and 2009. Key methodologic index score ≥ 2 was associated with the presence of funding from any source (10/25 vs. 1/19, P = 0.013) and funding from pharmaceutical industry (5/9 vs. 6/35, P = 0.03).

conclusionsWe identified deficiencies in the quality of supportive and palliative oncology RCTs.

Indexed as

BibliometricsPalliative CareHumansNeoplasmsPublishingQuality ControlRandomized Controlled Trials as TopicResearch DesignStatistics, Nonparametric

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.